These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 5037033

  • 21. Does prolonged pretreatment with large doses of spironolactone hasten a recovery from juxtaglomerular-adrenal suppression in primary aldosteronism?
    Morimoto S, Takeda R, Murakami M.
    J Clin Endocrinol Metab; 1970 Dec; 31(6):659-64. PubMed ID: 4921649
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Conn's syndrome presenting as depression.
    Khurshid KA, Weaver ME.
    Am J Psychiatry; 2005 Jun; 162(6):1226. PubMed ID: 15930081
    [No Abstract] [Full Text] [Related]

  • 26. [Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
    Gorbach HC, Bräuninger HJ.
    MMW Munch Med Wochenschr; 1975 Sep; 117(37):1483-6. PubMed ID: 810673
    [Abstract] [Full Text] [Related]

  • 27. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.
    Karagiannis A, Tziomalos K, Papageorgiou A, Kakafika AI, Pagourelias ED, Anagnostis P, Athyros VG, Mikhailidis DP.
    Expert Opin Pharmacother; 2008 Mar; 9(4):509-15. PubMed ID: 18312153
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [APROPOS OF A CASE OF CONN'S SYNDROME. THE DIFFERENTIAL DIAGNOSIS OF HYPERALDOSTERONISM WITH THE HELP OF DYNAMIC FUNCTION TESTS].
    DUPASQUIER E.
    Helv Med Acta; 1964 Nov; 31():426-31. PubMed ID: 14335446
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Association between Crohn's disease and Conn's syndrome. A report of two cases.
    Astegiano M, Bresso F, Demarchi B, Sapone N, Novero D, Palestro G, Resegotti A, Pellicano R, Rizzetto M.
    Panminerva Med; 2005 Mar; 47(1):61-4. PubMed ID: 15985978
    [Abstract] [Full Text] [Related]

  • 33. Primary aldosteronism due to adrenocortical adenoma (Conn's syndrome).
    Stein L, Shapiro N, Stein D.
    S Afr Med J; 1966 Nov 12; 40(41):993-6. PubMed ID: 5955092
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Modification of the effects of aldosterone on electrolyte excretion in man by simultaneous administration of corticosterone and hydrocortisone. Relevance to Conn's syndrome.
    ROSS EJ.
    J Clin Endocrinol Metab; 1960 Feb 12; 20():229-37. PubMed ID: 13854575
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists.
    Haschke F, Wimmer M, Parth K.
    Padiatr Padol; 1981 Feb 12; 16(3):317-26. PubMed ID: 7254888
    [Abstract] [Full Text] [Related]

  • 39. Myopathy and primary hyperaldosteronism.
    Schady W, Yuill GM.
    Neurology; 1981 Feb 12; 31(2):225-6. PubMed ID: 7193311
    [No Abstract] [Full Text] [Related]

  • 40. [Treatment of essential arterial hypertension with spironolactone: its value in the detection of primary hyperaldosteronism and prediction of its efficacy].
    Fournier A, Nakache JP, Salmon D, Kazandjian M, Baulon A, Legrand JC, Menard J, Lagrue G.
    J Urol Nephrol (Paris); 1972 Dec 12; 78(12):1023-7. PubMed ID: 4661188
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.